Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.hrthm.2020.04.047 http://scihub22266oqcxt.onion/10.1016/j.hrthm.2020.04.047 32387247!7200355!32387247     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Heart+Rhythm 2020 ; 17 (9): 1417-1422 Nephropedia Template TP {{tp|p=32387247|t=2020. Enhanced electrocardiographic monitoring of patients with Coronavirus Disease 2019 |pdf=|usr=}}{{32387247}} gab.com Text Enhanced electrocardiographic monitoring of patients with Coronavirus Disease 2019 JO: Heart Rhythm http://www.kidney.de/pget.php?&tw=1&pmid=32387247 #FOAvip BACKGROUND: Many of the drugs being used in the treatment of the ongoing pandemic coronavirus disease 2019 (COVID-19) are associated with QT prolongation. Expert guidance supports electrocardiographic (ECG) monitoring to optimize patient safety. OBJECTIVE: The purpose of this study was to establish an enhanced process for ECG monitoring of patients being treated for COVID-19. METHODS: We created a Situation Background Assessment Recommendation tool identifying the indication for ECGs in patients with COVID-19 and tagged these ECGs to ensure prompt over reading and identification of those with QT prolongation (corrected QT interval > 470 ms for QRS duration </= 120 ms; corrected QT interval > 500 ms for QRS duration > 120 ms). This triggered a phone call from the electrophysiology service to the primary team to provide management guidance and a formal consultation if requested. RESULTS: During a 2-week period, we reviewed 2006 ECGs, corresponding to 524 unique patients, of whom 103 (19.7%) met the Situation Background Assessment Recommendation tool-defined criteria for QT prolongation. Compared with those without QT prolongation, these patients were more often in the intensive care unit (60 [58.3%] vs 149 [35.4%]) and more likely to be intubated (32 [31.1%] vs 76 [18.1%]). Fifty patients with QT prolongation (48.5%) had electrolyte abnormalities, 98 (95.1%) were on COVID-19-related QT-prolonging medications, and 62 (60.2%) were on 1-4 additional non-COVID-19-related QT-prolonging drugs. Electrophysiology recommendations were given to limit modifiable risk factors. No patient developed torsades de pointes. CONCLUSION: This process functioned efficiently, identified a high percentage of patients with QT prolongation, and led to relevant interventions. Arrhythmias were rare. No patient developed torsades de pointes. Twit Text FOAVip Enhanced electrocardiographic monitoring of patients with Coronavirus Disease 2019 ????Heart Rhythm http://www.kidney.de/pget.php?&tw=1&pmid=32387247 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32387247 #FOAvip English Wikipedia <ref>{{Cite pmid|32387247}}</ref> Enhanced electrocardiographic monitoring of patients with Coronavirus Disease 2019 #MMPMID32387247 Jain S; Workman V; Ganeshan R; Obasare ER; Burr A; DeBiasi RM; Freeman JV; Akar J; Lampert R; Rosenfeld LE Heart Rhythm 2020[Sep]; 17 (9): 1417-1422 PMID32387247show ga BACKGROUND: Many of the drugs being used in the treatment of the ongoing pandemic coronavirus disease 2019 (COVID-19) are associated with QT prolongation. Expert guidance supports electrocardiographic (ECG) monitoring to optimize patient safety. OBJECTIVE: The purpose of this study was to establish an enhanced process for ECG monitoring of patients being treated for COVID-19. METHODS: We created a Situation Background Assessment Recommendation tool identifying the indication for ECGs in patients with COVID-19 and tagged these ECGs to ensure prompt over reading and identification of those with QT prolongation (corrected QT interval > 470 ms for QRS duration 500 ms for QRS duration > 120 ms). This triggered a phone call from the electrophysiology service to the primary team to provide management guidance and a formal consultation if requested. RESULTS: During a 2-week period, we reviewed 2006 ECGs, corresponding to 524 unique patients, of whom 103 (19.7%) met the Situation Background Assessment Recommendation tool-defined criteria for QT prolongation. Compared with those without QT prolongation, these patients were more often in the intensive care unit (60 [58.3%] vs 149 [35.4%]) and more likely to be intubated (32 [31.1%] vs 76 [18.1%]). Fifty patients with QT prolongation (48.5%) had electrolyte abnormalities, 98 (95.1%) were on COVID-19-related QT-prolonging medications, and 62 (60.2%) were on 1-4 additional non-COVID-19-related QT-prolonging drugs. Electrophysiology recommendations were given to limit modifiable risk factors. No patient developed torsades de pointes. CONCLUSION: This process functioned efficiently, identified a high percentage of patients with QT prolongation, and led to relevant interventions. Arrhythmias were rare. No patient developed torsades de pointes. |*Betacoronavirus[MESH] |*Electrocardiography[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Arrhythmias, Cardiac/*diagnosis/*etiology/therapy[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications/therapy[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/therapy[MESH] |Retrospective Studies[MESH] |Risk Factors[MESH]Enhanced electrocardiographic monitoring of patients with Coronavirus (epmc).pdf DeepDyve Pubget Overpricing